Autophagy-Associated lncRNAs: Promising Targets for Neurological Disease Diagnosis and Therapy

Neural Plast. 2020 Sep 22:2020:8881687. doi: 10.1155/2020/8881687. eCollection 2020.

Abstract

Neurological diseases are a major threat to global public health and prosperity. The number of patients with neurological diseases is increasing due to the population aging and increasing life expectancy. Autophagy is one of the crucial mechanisms to maintain nerve cellular homeostasis. Numerous studies have demonstrated that autophagy plays a dual role in neurological diseases. Long noncoding RNAs (lncRNAs) are a vital class of noncoding RNAs with a length of more than 200 nucleotides and cannot encode proteins themselves but are expressed in most neurological diseases. An early phase, emerging knowledge has revealed that long noncoding RNAs (lncRNAs) are crucial in autophagy regulation. Furthermore, autophagy-associated lncRNAs can promote the development of neurological diseases or slow their progression. In this review, we introduce a general overview of lncRNA functional mechanisms and summarizes the recent progress of lncRNAs on autophagy regulation in neurological diseases to reveal possible novel therapeutic targets or useful biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autophagy*
  • Humans
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / metabolism*
  • Nervous System Diseases / therapy
  • RNA, Long Noncoding / metabolism*

Substances

  • RNA, Long Noncoding